120 related articles for article (PubMed ID: 38236536)
1. Isolating Primary Tumor Cells from the MMTV-PyMT Mouse Model and Their Use in Developing an Orthotopic Mouse Model of Breast Cancer.
Kozak A; Vasiljeva O; Mikhaylov G
Methods Mol Biol; 2024; 2773():59-65. PubMed ID: 38236536
[TBL] [Abstract][Full Text] [Related]
2. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
3. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
4. Dietary Selenium Supplementation Does Not Attenuate Mammary Tumorigenesis-Mediated Bone Loss in Male MMTV-PyMT Mice.
Yan L; Nielsen FH; Sundaram S; Cao J
Biol Trace Elem Res; 2020 Mar; 194(1):221-227. PubMed ID: 31187394
[TBL] [Abstract][Full Text] [Related]
5. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
[TBL] [Abstract][Full Text] [Related]
6. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
[TBL] [Abstract][Full Text] [Related]
7. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
[TBL] [Abstract][Full Text] [Related]
8. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
[TBL] [Abstract][Full Text] [Related]
9. COX-2 modulates mammary tumor progression in response to collagen density.
Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
Nielsen BS; Egeblad M; Rank F; Askautrud HA; Pennington CJ; Pedersen TX; Christensen IJ; Edwards DR; Werb Z; Lund LR
PLoS One; 2008 Aug; 3(8):e2959. PubMed ID: 18698413
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice.
Lanza DG; Ma J; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S
Tumour Biol; 2012 Dec; 33(6):1997-2005. PubMed ID: 22836804
[TBL] [Abstract][Full Text] [Related]
12. Analyzing the Role of Proteases in Breast Cancer Progression and Metastasis Using Primary Cells from Transgenic Oncomice.
Vasiljeva O; Sevenich L; Reinheckel T
Methods Mol Biol; 2021; 2294():275-293. PubMed ID: 33742409
[TBL] [Abstract][Full Text] [Related]
13. Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo.
Attalla S; Taifour T; Bui T; Muller W
Oncogene; 2021 Jan; 40(3):475-491. PubMed ID: 33235291
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.
Berger T; Cheung CC; Elia AJ; Mak TW
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2995-3000. PubMed ID: 20133630
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.
Werbeck JL; Thudi NK; Martin CK; Premanandan C; Yu L; Ostrowksi MC; Rosol TJ
Vet Pathol; 2014 Jul; 51(4):868-81. PubMed ID: 24091811
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.
Boyle ST; Faulkner JW; McColl SR; Kochetkova M
Mol Cancer; 2015 Jun; 14():115. PubMed ID: 26047945
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Promotes Cardiac Dysfunction Through Deregulation of Cardiomyocyte Ca
da Costa TSR; Urias U; Negrao MV; Jordão CP; Passos CS; Gomes-Santos IL; Salemi VMC; Camargo AA; Brum PC; Oliveira EM; Hajjar LA; Chammas R; Filho RK; Negrao CE
J Am Heart Assoc; 2021 Feb; 10(5):e018076. PubMed ID: 33619982
[TBL] [Abstract][Full Text] [Related]
18. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.
Roselli S; Kahl RG; Copeland BT; Naylor MJ; Weidenhofer J; Muller WJ; Ashman LK
BMC Cancer; 2014 Jul; 14():509. PubMed ID: 25012362
[TBL] [Abstract][Full Text] [Related]
20. Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice.
He L; Zhu Z; Chen S; Wang Y; Gu H
Cancer Med; 2016 Jun; 5(6):1292-7. PubMed ID: 26992445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]